The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index; none of the 48 sources its claims cite is checked for support yet.
Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity
Open accessAbstract
A single mutation in protein kinase A remodels the intramolecular allostery, changing substrate specificity and regulation.
Overview
CoChat Summary
TL;DR
The Cushing’s syndrome driver mutation PKA-C L205R disrupts PKA’s internal allosteric network, reducing nucleotide/substrate binding cooperativity and canonical regulation while rewiring allostery toward noncanonical substrates such as VPS36. This single mutation alters both regulation and substrate specificity, explaining its multifaceted dysfunction.
Key findings
- L205R lowers ATPγN affinity threefold (Kd 215 ± 15 μM vs. 83 ± 8 μM for WT) and reduces PKI5–24 binding to ATPγN-saturated kinase 62-fold (Kd 10 ± 3 μM vs. 0.16 ± 0.02 μM), with binding cooperativity σ dropping from 106 ± 18 to 6 ± 2 (18-fold decrease).
- For canonical Kemptide, L205R increases KM 11-fold and kcat from 19 to 41 s−1, decreasing catalytic efficiency over fivefold; for noncanonical VPS36, kcat increases from 5 to ~18 s−1 and catalytic efficiency increases threefold, with mutant/ATPγN Kd = 3.5 ± 0.1 μM while WT binding cannot be detected reliably.
- NMR/CONCISE shows WT reaches a fully closed state with ATPγN/PKI, whereas the mutant only reaches a partially closed state; CHESCA reveals loss of allosteric correlations in the Gly-rich loop, activation loop, peptide-positioning loop, and αF/αG helices, while VPS36 binding rewires the network and reestablishes cooperativity.
- MD simulations show the mutant apo form explores a broader conformational basin, with the Gly-rich loop S53–G186 distance ranging from 5 to 18 Å and sampling an ATP-binding-occluded conformation; the activation loop can flip and form an R194–E86 salt bridge in the mutant/VPS36 complex.
Methods
- Recombinant human PKA-C WT and L205R were expressed in E. coli and purified; ITC measured ATPγN, PKI5–24, and VPS36 binding; steady-state coupled enzyme assays used Kemptide and VPS36; CD measured thermostability.
- Solution NMR used [1H,15N]-TROSY-HSQC at 600/900 MHz; CONCISE and CHESCA analyzed apo, ATPγN-bound, ATPγN/PKI-bound, and ATPγN/VPS36-bound states, with 55 residues used for CONCISE and a CHESCA correlation cutoff of 0.98.
- MD simulations started from PDB 1ATP and 4WB6; apo, binary, and ternary systems were run in GROMACS 4.6 with CHARMM36, each for 1.05 μs (total 3.15 μs, 157,500 conformations), followed by PCA, mutual information analysis, and HADDOCK docking for VPS36.
Limitations
- The paper states that VPS36 lacks the HAR, which might affect its binding kinetics and thermodynamics, and that 10 resonances in and around the Gly-rich loop were broadened beyond detection and excluded from CHESCA, so the extent of coordinated changes is largely underestimated.
- Evident from the text: the mechanistic conclusions rely on in vitro purified PKA-C, synthetic peptides, and MD simulations; no in vivo tumor model or patient sample validation is reported in this paper.
- Evident from the text: the study proposes that rewired allostery contributes to tumorigenesis but does not directly test causality in cells or animals.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Architecture of PKA-C and locations of the Cushing’s syndrome mutations. (A) Structure of PKA-C [Protein Data Bank (PDB) ID: 1ATP] in complex with pseudo-substrate PKI depicting the location of Cushing’s mutations (yellow spheres) in relation to structural elements of the kinase. The E248Q mutation includes an additional deletion (del243-247), and the S212R mutation includes an insertion (insIILR) not depicted. (B) X-ray structure of PKA-CL205R (PDB ID: 4WB6) with the overlay of PKI5–24 (PKIWT from PDB ID: 1ATP) describing the architecture of the peptide binding site and steric clash between kinase (PKA-CL205R) and pseudo-substrate. (C) Structure of the R/C complex (PDB ID: 2QCS) depicting locations of Cushing’s mutations in relation to the pseudo-substrate inhibitory sequence of the R-subunit. (D) Primary sequence comparison of common regulators (RIα, RIIβ, and PKI) and peptide substrates of the catalytic subunit (Kemptide and VPS36).](/paper-figures/a850a95d2f554c0e89fec678adb12977/cushings-syndrome-driver-mutation-disrupts-protein-kinase-a-allosteric-network-figure-1.jpg)


![Fig. 4 Conformational dynamics of the activation loop of PKA-CWT and PKA-CL205R upon binding substrate. (A) Distinct opening-closing motions of the Gly-rich loop highlighting the hindered conformation that occludes the entering of ATP in PKA-CL205R. (B) Probability density describing the conformation of the activation loop in response to different substrates and pseudo-substrates. (C) [1H, 15N]-TROSY-HSQC spectra showing the backbone amide chemical shift changes of the W196 indole amide (located on the activation loop) in response to binding PKI or VPS36. (D) X-ray structure of PKA-CWT (gray) (PDB ID: 1ATP) with the overlay PKA-CL205R in complex with PKI (light blue) (PDB ID: 4WB6) describing the architecture of the peptide binding site and activation loop flip. (E) X-ray structure of PKA-CWT (gray) (PDB ID: 1ATP) with the overlay PKA-CL205R in complex with VPS36 (light blue) (MD simulations) describing the architecture of the peptide binding site and activation loop flip.](/paper-figures/3306ba4ab574429bb942bac1a39fdb18/cushings-syndrome-driver-mutation-disrupts-protein-kinase-a-allosteric-network-figure-4.jpg)


Verification
Claims the paper makes
0 Valid · 0 Not valid · 30 Not checked · 87 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The CONCISE analysis shows that the conformation of the PKA-CWT/ATPγN/VPS36 complex only reaches the intermediate state.”
§ Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity > RESULTS > Binding of VPS36 substrate to PKA-CL205R rewires the intramolecular allosteric network and reestablishes binding cooperativity
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The recognition sequence of VPS36 (RRLSEEM) for PKA-C has two Glu residues in the P+1 and P+2 positions.”
§ Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity > RESULTS > Binding of VPS36 substrate to PKA-CL205R rewires the intramolecular allosteric network and reestablishes binding cooperativity
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, the N terminus of VPS36 forms transient interactions with the C-terminal tail located in the small lobe of PKA-CL205R, which are absent in the corresponding complex with PKI.”
§ Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity > RESULTS > PKA-CWT and PKA-CL205R explore different conformational states
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“When saturated with ATPγN, PKA-CWT binds PKI5–24 with higher affinity (Kd = 0.16 ± 0.02 μM) (18).”
§ Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity > RESULTS > PKA-CL205R shows a marked loss of binding cooperativity between ATP and PKI
What the sources say
- Not checked yetcites [18] Kim J., Li G., Walters M. A., Taylor S. S., Veglia G., Uncoupling catalytic and binding functions in the cyclic amp-dependent protein kinase A. Structure 24, 353– 363 (2016). 26833386 PMC4775281 doi:10.1016/j.str.2015.11.016
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that PKA-CL205R exhibits a threefold lower binding affinity compared to PKA-CWT [Kd (dissociation constant) of 215 ± 15 μM versus 83 ± 8 μM, respectively].”
§ Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity > RESULTS > PKA-CL205R shows a marked loss of binding cooperativity between ATP and PKI
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
57 more claims
Create a free account to see all 117 claims and to verify the 48 references still open.
- It may state two separate claims as one. 46
- Probably not a substantial claim. 12
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity > RESULTS > Binding of VPS36 substrate to PKA-CL205R rewires the intramolecular allosteric network and reestablishes binding cooperativity
“a VPS36-derived peptide (residues 115 to 130 encompassing the PKA-C recognition sequence and denoted VPS36 from hereon)”
§ Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity > MATERIALS AND METHODS > Sample preparation
“The VPS36 peptide sequence used for all studies is as follows: QIEFYRRLSEEMTQR.”
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation
Hess, B., Kutzner, C., van der Spoel, D., & Lindahl, E. (2008) · Journal of Chemical Theory and Computation · doi:10.1021/ct700301q · Cited by 15,908
Best, R. B., Zhu, X., Shim, J., Lopes, P. E. M., Mittal, J., Feig, M., & MacKerell, A. D. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct300400x · Cited by 4,532
HADDOCK: A Protein−Protein Docking Approach Based on Biochemical or Biophysical Information
Dominguez, C., Boelens, R., & Bonvin, A. M. J. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja026939x · Cited by 3,187
Rapid measurement of binding constants and heats of binding using a new titration calorimeter
Wiseman, T., Williston, S., Brandts, J. F., & Lin, L.-N. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90213-3 · Cited by 2,675
Pervushin, K., Riek, R., Wider, G., & Wüthrich, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12366 · Cited by 2,445
NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy
Lee, W., Tonelli, M., & Markley, J. L. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu830 · Cited by 2,045
Knighton, D. R., Zheng, J., Ten Eyck, L. F., Ashford, V. A., Xuong, N.-H., Taylor, S. S., & Sowadski, J. M. (1991) · Science · doi:10.1126/science.1862342 · Cited by 1,759
Self-citationPERVUSHIN, K., RIEK, R., WIDER, G., & WÜTHRICH, K. (2021) · NMR with Biological Macromolecules in Solution · doi:10.1142/9789811235795_0006 · Cited by 951
Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma
Honeyman, J. N., Simon, E. P., Robine, N., Chiaroni-Clarke, R., Darcy, D. G., Lim, I. I. P., Gleason, C. E., Murphy, J. M., Rosenberg, B. R., Teegan, L., et al. (2014) · Science · doi:10.1126/science.1249484 · Cited by 494
Cited by
Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs
Nussinov, R., Zhang, M., Maloney, R., Liu, Y., Tsai, C.-J., & Jang, H. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167569 · Cited by 66
Metadata
- Authors
- Walker, C., Wang, Y., Olivieri, C., Karamafrooz, A., Casby, J., Bathon, K., Calebiro, D., Gao, J., Bernlohr, D. A., Taylor, S. S., & Veglia, G.
- Affiliations
- University of Minnesota (US)
- University of Würzburg (DE)
- University of Birmingham (GB)
- University of California San Diego (US)
- Corresponding author
- Veglia, Gianluigi
- ORCID
- Venue
- Science Advances
- Published
- 2019-08-02
- Volume
- 5
- Issue
- 8
- Pages
- eaaw9298-eaaw9298
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6713507
- OpenAlex
- W2971185131
- Semantic Scholar
- c22aea1e5bacf4bf2901eadd40cac91df5f52067
- Cited by
- 71
- References
- 47
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 10 · 2023: 15 · 2022: 16 · 2021: 7 · 2020: 8
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by-nc)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc)
- Funders
- NIH Office of the Director (GM100310, S10 OD021536)
- IKZF Wuerzburg (B-281)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Cushing's syndrome, driver mutations, protein kinase A, allosteric regulation, substrate specificity, phosphorylation, adrenal adenoma
- MeSH terms
- Allosteric Regulation, Cushing Syndrome, Humans, Hydrocortisone, Mutation, Substrate Specificity, Cyclic AMP-Dependent Protein Kinases, Adrenocortical Adenoma, Catalytic Domain, Cyclic AMP-Dependent Protein Kinase Catalytic Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity. https://app.cochat.ai/papers/10.1126/sciadv.aaw9298
- The paper
- Walker, C., Wang, Y., Olivieri, C., Karamafrooz, A., Casby, J., Bathon, K., Calebiro, D., Gao, J., Bernlohr, D. A., Taylor, S. S., & Veglia, G. (2019). Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity. Science Advances. https://doi.org/10.1126/sciadv.aaw9298
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.